|
市場調査レポート
商品コード
1172713
がん診断におけるAIの世界市場規模、シェア、産業動向分析レポート：エンドユーザー別、コンポーネント別、がんタイプ別、地域別展望と予測、2022年～2028年Global AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
|
|
|||||||
| がん診断におけるAIの世界市場規模、シェア、産業動向分析レポート：エンドユーザー別、コンポーネント別、がんタイプ別、地域別展望と予測、2022年～2028年 |
|
出版日: 2022年11月30日
発行: KBV Research
ページ情報: 英文 228 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
がん診断におけるAIの世界市場規模は、予測期間中にCAGR28.6％で成長し、2028年には5億900万米ドルに達すると予測されます。
さらに、これらのアルゴリズムは、新しいデータに触れることで更新され続け、情報を得ることができます。ディープラーニングは、機械学習やAIとともに、がんの検出に使用されます。また、人間の脳が全身からの信号を収集、分析、反応する方法を再現した人工神経回路網も利用します。NCIの学内研究プログラムの研究者たちは、前立腺がんや子宮頸がんのがん検査を強化するために、AIの完全な能力を活用しています。
15年前、NCIの医師は、MRIを用いた生検を開始し、研究者が前立腺のがんの可能性がある部分に狙いを定めることができるようになりました。MRI生検は、前立腺がんの専門家が行う検出と治療を強化しました。さらに、AIは臨床医の診断スキルを記録するだけでなく、全国のクリニックが臨床診断と意思決定を支援するためのアルゴリズムを利用できるようにします。
COVID-19インパクト分析
コロナウイルスは、がん診断におけるAI市場にポジティブな影響を与えました。AIと機械学習の導入は、医療機関や臨床施設の作業負担の軽減を支援しました。業界の成長に伴い、多くの国際的なITジャガーノットがコロナウイルスを特定するためのAIツールやソフトウェアの開発に乗り出し、後にがん症状の検出に役立つことになりました。コロナウイルス患者によるヘルスケア専門家の不足は、より良い患者支援と結果を得るためのAIソリューションの採用を後押しします。診断、アフターケア、およびその他の手順は、時間がかかるため、パンデミックの間に維持することが困難でした。
市場の成長要因
ヘルスケア分野での技術進歩の増加
がん診断の検出における技術や人工知能の採用は、ヘルスケア分野の成長を促進します。人工ツールには、低価格の診断手順と迅速な検出データ生成のニーズが含まれています。また、がんの検出とスクリーニングのためのヘルスケア分野における技術開発の需要は、業界の成長をサポートすると予想されます。さらに、政府支出によるヘルスケアの技術強化が、新興国のヘルスケア分野の成長を後押ししています。
がん早期診断のニーズの高まり
早期がん診断に対する意識の高まりが、がん診断におけるAIの成長を後押ししています。医療機関とともに、医療従事者が患者の改善と治療の進歩のためにAI技術を病院に組み合わせることを促進する政府プログラムの数が増加しています。さらに、技術の採用は、民間組織や非営利団体が強化された医療結果を提供し、人々の間で早期診断を増加させる治療費の削減を支援します。
市場抑制要因
ヘルスケア分野におけるAI活用の理解不足
AIシステムと機械学習の知識とトレーニングに加え、巨大なデータセットとデータベースを管理することが、ディープラーニング技術の最大の障壁となっています。しかし、AIの活用は、ゲノム配列などの重要な個人データを提供する可能性があるため、データ漏洩の問題をもたらすこともあります。成長を制限するさまざまな問題には、透明性の欠如、AIアルゴリズムの偏りのリスク、学習目的で利用されるデータ、臨床現場でのAI導入権限に伴う問題発生が含まれます。哲学的な問題は、人工知能が直面する最も困難な問題の1つです。
エンドユーザーの展望
エンドユーザー別では、がん診断におけるAI市場は、病院、手術センター・医療機関、その他に分類されます。2021年のがん診断におけるAI市場では、手術センター・医療機関セグメントが顕著な収益シェアを記録しました。AIの採用により、誤解を招くネガティブやポジティブのケースが減少し、より充実した患者結果を提供できるようになったからです。医療教育の進化は、ヘルスケアの成長とともに推進されています。さらに、AIの実装とより良い発明のためのデータ学習の活用による医療の導入と実践は、業界の成長と意思決定を強化します。
コンポーネントの展望
コンポーネントに基づき、がん診断におけるAI市場は、ソフトウェアソリューション・ハードウェア、およびサービスに区分されます。ソフトウェアソリューションセグメントは、2021年のがん診断におけるAI市場で最高の収益シェアを獲得しました。それは、多くの大手競合企業が、がん診断のための新しいソリューションを発表しているからです。ソフトウェアの助けを借りて、医師は効率的かつ正確にがんや腫瘍の微細なサイズを特定することができます。さらに、人工知能ソフトウェアは、人間の診断システムよりも正確で信頼性が高いです。このソフトウェアプラットフォームは高品質の分析を提供し、迅速な結果は医師の信頼性を高め、人間の安全性とともに生産性を向上させます。
がんの種類別の展望
がん診断におけるAI市場は、がんタイプに基づいて、乳がん、肺がん、前立腺がん・大腸がん、脳腫瘍、皮膚がん・子宮頸がん、その他に分けられます。乳がんセグメントは、2021年のがん診断におけるAI市場で最大の収益シェアを調達しました。乳房の細胞が制御不能になり、乳がんの発生率が高まっているためです。乳がんは、がんとして出てきた乳房のどの細胞が感染しているかに依存します。乳房は、乳管、小葉、結合組織を含む3つのコンポーネントで構成されています。
地域別展望
地域別では、がん診断におけるAI市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米セグメントは、2021年にがん診断におけるAI市場で最大の収益シェアを獲得しました。最新のヘルスケアインフラへのアクセス性と共に、がんの有病率が増加していることが、市場の成長を促進しています。しかし、政府のイニシアチブの増加や医療分野への支出は、医療分野におけるAIの成長を促進します。患者の診断数の増加は、この地域のがん診断におけるAIの成長を推進します。
市場参入企業がとる主な戦略は、パートナーシップです。Cardinal matrixで提示された分析に基づき、Microsoft Corporationはがん診断におけるAI市場の先駆者です。Flatiron Health（F. Hoffmann-La Roche Ltd.）, Paige AI, Inc., PathAI, Inc.などの企業は、がん診断におけるAI市場における主要な革新者の一人です。
目次
第1章 市場の範囲と調査手法
- 市場の定義
- 目的
- 市場規模
- セグメンテーション
- がん診断におけるAIの世界市場、エンドユーザー別
- がん診断におけるAIの世界市場、コンポーネント別
- がん診断におけるAIの世界市場、がんの種類別
- がん診断におけるAIの世界市場、地域別
- 調査手法
第2章 市場概要
- イントロダクション
- 概要の説明
- 市場の構成とシナリオ
- 概要の説明
- 市場に影響を与える主要因
- 市場促進要因
- 市場の抑制要因
第3章 競合分析-世界
- KBVカーディナルマトリックス
- 最近の業界全体の戦略的展開
- パートナーシップ、コラボレーション、契約
- 製品上市と製品拡張
- 買収と合併
- 主要成功戦略
- 主要なリーディング戦略：割合の分布（2018-2022年）
- 主要な戦略的動き：（パートナーシップ、コラボレーション、契約：2019年、12月～2022年、11月）主要なプレーヤーたち
第4章 がん診断におけるAIの世界市場：エンドユーザー別
- 世界の病院市場：地域別
- 世界の外科センター・医療機関市場：地域別
- 世界のその他地域別市場
第5章 がん診断におけるAIの世界市場：コンポーネント別
- ソフトウェアソリューションの世界市場：地域別
- ハードウェアの世界市場：地域別
- 地域別サービス世界市場
第6章 がん診断におけるAIの世界市場：がんタイプ別
- 乳がんの地域別世界市場
- 肺がんの世界市場：地域別
- 脳腫瘍の世界市場：地域別
- 皮膚がん・子宮頸がんの世界地域別市場
- 前立腺がん・大腸がんの世界市場：地域別
- その他の地域別世界市場
第7章 がん診断におけるAIの世界市場：地域別
- 北米
- 北米のがん診断におけるAIの国別市場
- 米国
- カナダ
- メキシコ
- その他北米地域
- 北米のがん診断におけるAIの国別市場
- 欧州
- 欧州のがん診断におけるAI市場：国別
- ドイツ
- 英国
- フランス
- ロシア
- スペイン
- イタリア
- その他欧州
- 欧州のがん診断におけるAI市場：国別
- アジア太平洋地域
- アジア太平洋地域のがん診断におけるAI市場：国別
- 中国
- 日本
- インド
- 韓国
- シンガポール
- マレーシア
- その他アジア太平洋地域
- アジア太平洋地域のがん診断におけるAI市場：国別
- LAMEA
- LAMEAのがん診断におけるAI市場：国別
- ブラジル
- アルゼンチン
- UAE
- サウジアラビア
- 南アフリカ共和国
- ナイジェリア
- LAMEAの他の地域
- LAMEAのがん診断におけるAI市場：国別
第8章 企業プロファイル
- Microsoft Corporation
- Flatiron Health（F. Hoffmann-La Roche Ltd.）
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o
- Medial EarlySign
- Kheiron Medical Technologies Limited
LIST OF TABLES
- TABLE 1 Global AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 2 Global AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 3 Partnerships, Collaborations and Agreements- AI In Cancer Diagnostics Market
- TABLE 4 Product Launches And Product Expansions- AI In Cancer Diagnostics Market
- TABLE 5 Acquisition and Mergers- AI In Cancer Diagnostics Market
- TABLE 6 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 7 Global AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 8 Global Hospital Market by Region, 2018 - 2021, USD Thousands
- TABLE 9 Global Hospital Market by Region, 2022 - 2028, USD Thousands
- TABLE 10 Global Surgical Centers & Medical Institutes Market by Region, 2018 - 2021, USD Thousands
- TABLE 11 Global Surgical Centers & Medical Institutes Market by Region, 2022 - 2028, USD Thousands
- TABLE 12 Global Others Market by Region, 2018 - 2021, USD Thousands
- TABLE 13 Global Others Market by Region, 2022 - 2028, USD Thousands
- TABLE 14 Global AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 15 Global AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 16 Global Software Solutions Market by Region, 2018 - 2021, USD Thousands
- TABLE 17 Global Software Solutions Market by Region, 2022 - 2028, USD Thousands
- TABLE 18 Global Hardware Market by Region, 2018 - 2021, USD Thousands
- TABLE 19 Global Hardware Market by Region, 2022 - 2028, USD Thousands
- TABLE 20 Global Services Market by Region, 2018 - 2021, USD Thousands
- TABLE 21 Global Services Market by Region, 2022 - 2028, USD Thousands
- TABLE 22 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 23 Global AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 24 Global Breast Cancer Market by Region, 2018 - 2021, USD Thousands
- TABLE 25 Global Breast Cancer Market by Region, 2022 - 2028, USD Thousands
- TABLE 26 Global Lung Cancer Market by Region, 2018 - 2021, USD Thousands
- TABLE 27 Global Lung Cancer Market by Region, 2022 - 2028, USD Thousands
- TABLE 28 Global Brain Tumor Market by Region, 2018 - 2021, USD Thousands
- TABLE 29 Global Brain Tumor Market by Region, 2022 - 2028, USD Thousands
- TABLE 30 Global Skin Cancer & Cervical Cancer Market by Region, 2018 - 2021, USD Thousands
- TABLE 31 Global Skin Cancer & Cervical Cancer Market by Region, 2022 - 2028, USD Thousands
- TABLE 32 Global Prostate & Colorectal Cancer Market by Region, 2018 - 2021, USD Thousands
- TABLE 33 Global Prostate & Colorectal Cancer Market by Region, 2022 - 2028, USD Thousands
- TABLE 34 Global Others Market by Region, 2018 - 2021, USD Thousands
- TABLE 35 Global Others Market by Region, 2022 - 2028, USD Thousands
- TABLE 36 Global AI In Cancer Diagnostics Market by Region, 2018 - 2021, USD Thousands
- TABLE 37 Global AI In Cancer Diagnostics Market by Region, 2022 - 2028, USD Thousands
- TABLE 38 North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 39 North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 40 North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 41 North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 42 North America Hospital Market by Country, 2018 - 2021, USD Thousands
- TABLE 43 North America Hospital Market by Country, 2022 - 2028, USD Thousands
- TABLE 44 North America Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
- TABLE 45 North America Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
- TABLE 46 North America Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 47 North America Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 48 North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 49 North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 50 North America Software Solutions Market by Country, 2018 - 2021, USD Thousands
- TABLE 51 North America Software Solutions Market by Country, 2022 - 2028, USD Thousands
- TABLE 52 North America Hardware Market by Country, 2018 - 2021, USD Thousands
- TABLE 53 North America Hardware Market by Country, 2022 - 2028, USD Thousands
- TABLE 54 North America Services Market by Country, 2018 - 2021, USD Thousands
- TABLE 55 North America Services Market by Country, 2022 - 2028, USD Thousands
- TABLE 56 North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 57 North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 58 North America Breast Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 59 North America Breast Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 60 North America Lung Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 61 North America Lung Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 62 North America Brain Tumor Market by Country, 2018 - 2021, USD Thousands
- TABLE 63 North America Brain Tumor Market by Country, 2022 - 2028, USD Thousands
- TABLE 64 North America Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 65 North America Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 66 North America Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 67 North America Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 68 North America Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 69 North America Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 70 North America AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
- TABLE 71 North America AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
- TABLE 72 US AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 73 US AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 74 US AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 75 US AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 76 US AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 77 US AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 78 US AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 79 US AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 80 Canada AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 81 Canada AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 82 Canada AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 83 Canada AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 84 Canada AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 85 Canada AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 86 Canada AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 87 Canada AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 88 Mexico AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 89 Mexico AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 90 Mexico AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 91 Mexico AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 92 Mexico AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 93 Mexico AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 94 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 95 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 96 Rest of North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 97 Rest of North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 98 Rest of North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 99 Rest of North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 100 Rest of North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 101 Rest of North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 102 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 103 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 104 Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 105 Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 106 Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 107 Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 108 Europe Hospital Market by Country, 2018 - 2021, USD Thousands
- TABLE 109 Europe Hospital Market by Country, 2022 - 2028, USD Thousands
- TABLE 110 Europe Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
- TABLE 111 Europe Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
- TABLE 112 Europe Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 113 Europe Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 114 Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 115 Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 116 Europe Software Solutions Market by Country, 2018 - 2021, USD Thousands
- TABLE 117 Europe Software Solutions Market by Country, 2022 - 2028, USD Thousands
- TABLE 118 Europe Hardware Market by Country, 2018 - 2021, USD Thousands
- TABLE 119 Europe Hardware Market by Country, 2022 - 2028, USD Thousands
- TABLE 120 Europe Services Market by Country, 2018 - 2021, USD Thousands
- TABLE 121 Europe Services Market by Country, 2022 - 2028, USD Thousands
- TABLE 122 Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 123 Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 124 Europe Breast Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 125 Europe Breast Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 126 Europe Lung Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 127 Europe Lung Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 128 Europe Brain Tumor Market by Country, 2018 - 2021, USD Thousands
- TABLE 129 Europe Brain Tumor Market by Country, 2022 - 2028, USD Thousands
- TABLE 130 Europe Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 131 Europe Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 132 Europe Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 133 Europe Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 134 Europe Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 135 Europe Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 136 Europe AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
- TABLE 137 Europe AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
- TABLE 138 Germany AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 139 Germany AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 140 Germany AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 141 Germany AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 142 Germany AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 143 Germany AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 144 Germany AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 145 Germany AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 146 UK AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 147 UK AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 148 UK AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 149 UK AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 150 UK AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 151 UK AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 152 UK AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 153 UK AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 154 France AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 155 France AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 156 France AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 157 France AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 158 France AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 159 France AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 160 France AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 161 France AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 162 Russia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 163 Russia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 164 Russia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 165 Russia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 166 Russia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 167 Russia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 168 Russia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 169 Russia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 170 Spain AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 171 Spain AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 172 Spain AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 173 Spain AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 174 Spain AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 175 Spain AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 176 Spain AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 177 Spain AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 178 Italy AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 179 Italy AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 180 Italy AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 181 Italy AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 182 Italy AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 183 Italy AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 184 Italy AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 185 Italy AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 186 Rest of Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 187 Rest of Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 188 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 189 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 190 Rest of Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 191 Rest of Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 192 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 193 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 194 Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 195 Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 196 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 197 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 198 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Thousands
- TABLE 199 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Thousands
- TABLE 200 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
- TABLE 201 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
- TABLE 202 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 203 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 204 Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 205 Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 206 Asia Pacific Software Solutions Market by Country, 2018 - 2021, USD Thousands
- TABLE 207 Asia Pacific Software Solutions Market by Country, 2022 - 2028, USD Thousands
- TABLE 208 Asia Pacific Hardware Market by Country, 2018 - 2021, USD Thousands
- TABLE 209 Asia Pacific Hardware Market by Country, 2022 - 2028, USD Thousands
- TABLE 210 Asia Pacific Services Market by Country, 2018 - 2021, USD Thousands
- TABLE 211 Asia Pacific Services Market by Country, 2022 - 2028, USD Thousands
- TABLE 212 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 213 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 214 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 215 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 216 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 217 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 218 Asia Pacific Brain Tumor Market by Country, 2018 - 2021, USD Thousands
- TABLE 219 Asia Pacific Brain Tumor Market by Country, 2022 - 2028, USD Thousands
- TABLE 220 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 221 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 222 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 223 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 224 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 225 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 226 Asia Pacific AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
- TABLE 227 Asia Pacific AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
- TABLE 228 China AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 229 China AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 230 China AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 231 China AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 232 China AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 233 China AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 234 China AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 235 China AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 236 Japan AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 237 Japan AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 238 Japan AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 239 Japan AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 240 Japan AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 241 Japan AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 242 Japan AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 243 Japan AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 244 India AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 245 India AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 246 India AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 247 India AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 248 India AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 249 India AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 250 India AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 251 India AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 252 South Korea AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 253 South Korea AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 254 South Korea AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 255 South Korea AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 256 South Korea AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 257 South Korea AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 258 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 259 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 260 Singapore AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 261 Singapore AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 262 Singapore AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 263 Singapore AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 264 Singapore AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 265 Singapore AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 266 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 267 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 268 Malaysia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 269 Malaysia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 270 Malaysia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 271 Malaysia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 272 Malaysia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 273 Malaysia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 274 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 275 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 276 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 277 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 278 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 279 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 280 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 281 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 282 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 283 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 284 LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 285 LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 286 LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 287 LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 288 LAMEA Hospital Market by Country, 2018 - 2021, USD Thousands
- TABLE 289 LAMEA Hospital Market by Country, 2022 - 2028, USD Thousands
- TABLE 290 LAMEA Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
- TABLE 291 LAMEA Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
- TABLE 292 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 293 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 294 LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 295 LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 296 LAMEA Software Solutions Market by Country, 2018 - 2021, USD Thousands
- TABLE 297 LAMEA Software Solutions Market by Country, 2022 - 2028, USD Thousands
- TABLE 298 LAMEA Hardware Market by Country, 2018 - 2021, USD Thousands
- TABLE 299 LAMEA Hardware Market by Country, 2022 - 2028, USD Thousands
- TABLE 300 LAMEA Services Market by Country, 2018 - 2021, USD Thousands
- TABLE 301 LAMEA Services Market by Country, 2022 - 2028, USD Thousands
- TABLE 302 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 303 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 304 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 305 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 306 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 307 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 308 LAMEA Brain Tumor Market by Country, 2018 - 2021, USD Thousands
- TABLE 309 LAMEA Brain Tumor Market by Country, 2022 - 2028, USD Thousands
- TABLE 310 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 311 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 312 LAMEA Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 313 LAMEA Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 314 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 315 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 316 LAMEA AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
- TABLE 317 LAMEA AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
- TABLE 318 Brazil AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 319 Brazil AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 320 Brazil AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 321 Brazil AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 322 Brazil AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 323 Brazil AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 324 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 325 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 326 Argentina AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 327 Argentina AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 328 Argentina AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 329 Argentina AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 330 Argentina AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 331 Argentina AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 332 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 333 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 334 UAE AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 335 UAE AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 336 UAE AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 337 UAE AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 338 UAE AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 339 UAE AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 340 UAE AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 341 UAE AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 342 Saudi Arabia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 343 Saudi Arabia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 344 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 345 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 346 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 347 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 348 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 349 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 350 South Africa AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 351 South Africa AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 352 South Africa AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 353 South Africa AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 354 South Africa AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 355 South Africa AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 356 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 357 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 358 Nigeria AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 359 Nigeria AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 360 Nigeria AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 361 Nigeria AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 362 Nigeria AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 363 Nigeria AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 364 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 365 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 366 Rest of LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 367 Rest of LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 368 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 369 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 370 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 371 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 372 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 373 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 374 key information - Microsoft Corporation
- TABLE 375 Key Information - Flatiron Health
- TABLE 376 Key Information -Paige AI, Inc.
- TABLE 377 Key Information - PathAI, Inc.
- TABLE 378 Key Information -Therapixel
- TABLE 379 Key Information - Tempus, Inc.
- TABLE 380 Key Information - SkinVision BV
- TABLE 381 Key Information - Cancer Center Sp. z o.o.
- TABLE 382 Key Information - Medial EarlySign
- TABLE 383 Key Information - Kheiron Medical Technologies Limited
List of Figures
- FIG 1 Methodology for the research
- FIG 2 KBV Cardinal Matrix
- FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
- FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
- FIG 5 Global AI In Cancer Diagnostics Market Share by End-user, 2021
- FIG 6 Global AI In Cancer Diagnostics Market Share by End-user, 2028
- FIG 7 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2028, USD Thousands
- FIG 8 Global AI In Cancer Diagnostics Market Share by Component, 2021
- FIG 9 Global AI In Cancer Diagnostics Market Share by Component, 2028
- FIG 10 Global AI In Cancer Diagnostics Market by Component, 2018 - 2028, USD Thousands
- FIG 11 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2021
- FIG 12 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2028
- FIG 13 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2028, USD Thousands
- FIG 14 Global AI In Cancer Diagnostics Market Share by Region, 2021
- FIG 15 Global AI In Cancer Diagnostics Market Share by Region, 2028
- FIG 16 Global AI In Cancer Diagnostics Market by Region, 2018 - 2028, USD Thousands
- FIG 17 SWOT Analysis: Microsoft Corporation
- FIG 18 Recent strategies and developments: Paige AI, Inc.
- FIG 19 Recent strategies and developments: PathAI, Inc.
The Global AI In Cancer Diagnostics Market size is expected to reach $509 million by 2028, rising at a market growth of 28.6% CAGR during the forecast period.
Artificial intelligence is an algorithm or computer program that utilizes data or information to make predictions and conclusions. To develop an algorithm, developers have created a bunch of rules or guidelines for the computer to follow the rules and commands. For an instant, Dr. Turkbey along with his team leveraged the current rules about prostate cancer that showed up on the MRI scan machine.
With the help of the machine crew utilized thousands of MRI research in their algorithm, which concluded many people has prostate cancer whereas many of them didn't have any signs of cancer. The algorithm enrolls in how to evaluate and understand data while utilizing machine learning or artificial intelligence. Machine learning may utilize data that are not visible to the human brain or eyes.
Moreover, these algorithms keep on updating and being informed as they are exposed to new data. Deep learning along with machine learning and AI in the detection of cancer. It also utilizes Artificial neural networks which replicate how the human brain collects, analyzes, and reacts to the signals from the entire body. Researchers in NCI's intramural research program is utilizing the complete abilities of AI to enhance cancer testing in prostate and cervical cancer.
15 years ago, NCI physicians started executing biopsies backed by Magnetic resonance imaging, allowing researchers to target the areas of the prostate which could be cancerous. MRI biopsy enhanced the detection and treatment performed by prostate cancer professionals. Moreover, AI helps clinicians to record their diagnostic skills as well as makes algorithms available for clinics across the nation to assist with clinical diagnostics and decision-making.
COVID - 19 Impact Analysis
The coronavirus had a positive impact on AI in the cancer diagnostic market. The implementation of the AI and machine learning assisted to reduce the workload of the health care and clinical facilities. With the growth of the industry, many international IT juggernauts have stepped with to develop AI tools and software to identify the coronavirus which would later help in detecting cancer symptoms. The shortage of healthcare professionals due to the coronavirus cases drives the adoption of AI solutions for better patient assistance and results. The diagnosis, aftercare, and other procedure were hard to maintain during the pandemic as they were time-consuming.
Market Growth Factors
Increasing technological advancements in the healthcare sector
The technologies and the adoption of artificial intelligence in the detection of cancer diagnostics propel the growth of the healthcare sector. The artificial tools contain the need for low-price diagnostic procedures and quick detection data generation. The demand for technology developments in the healthcare sector for detecting and screening cancer is also anticipated to support industry growth. Moreover, the technological enhancement in healthcare by government spending drives the growth of the health care sectors in emerging nations.
Growing need for early cancer diagnosis
The growing awareness of early cancer diagnostics drives the growth of AI in cancer diagnostics. The rise in the number of government programs to promote healthcare organizations along with healthcare providers to combine AI technologies in their hospitals for the betterment and advance the therapy of the patients. Moreover, the adoption of the technologies helps private organizations and nonprofit organizations to deliver enhanced medical results and the reduced cost of treatment which increases early diagnostic among people.
Market Restraining Factors
Lack of Understanding of AI Use in the Healthcare Sector
Managing huge datasets and databases along with the knowledge & training of AI systems and machine learning is the biggest barrier to deep learning technologies. However, the utilization of AI can also bring the issue of data breaches because it could provide crucial individual data such as genomic sequences. The various issues restricting the growth include the lack of transparency, risk of bias for the AI algorithms, data utilized for training purposes, and problem encounters while AI implementation authority in clinical settings. Philosophical issues are one of the thorniest problems faced in artificial intelligence.
End-User Outlook
By End-user, the AI in Cancer Diagnostics Market is classified into Hospital, Surgical Centers and Medical Institutes, and Others. The surgical centers & medical institutes segment registered a remarkable revenue share in the AI in cancer diagnostics market in 2021. It is because the adoption of AI has reduced the cases of misleading negatives and positives to deliver enhanced patient results. The evolution of medical education is propelling along with the growth of healthcare. Moreover, the adoption and practice of medicine with the implementation of AI and the utilization of data learning for better invention enhance the growth and decision making in the industry.
Component Outlook
Based on the Component, the AI in Cancer Diagnostics Market is segmented into Software Solutions Hardware, and Services. The software solutions segment acquired the highest revenue share in the AI in cancer diagnostics market in 2021. It is because many big competitors are launching new solutions for the diagnosis of cancer. With the help of the software, doctors can efficiently and precisely identify the micro size of cancer or tumor. Moreover, artificial intelligence software is more precise and trustworthy than the human diagnostic system. The software platform provides high-quality analytics, and quick results grow the confidence of the doctors as well as boost productivity along with human safety.
Cancer Type Outlook
On the basis of Cancer Type, the AI in Cancer Diagnostics Market is divided into Breast Cancer, Lung Cancer, Prostate & Colorectal Cancer, Brain Tumor, Skin Cancer & Cervical Cancer and Others. The breast cancer segment procured the largest revenue share in the AI in cancer diagnostics market in 2021. It is because the incidence of breast cancer is growing due to the cells in the breast growing out of control. Breast cancer depends on which cell is infected in the breast which came out as cancer. The breast is made up of three components which include ducts, lobules, and connective tissue.
Regional Outlook
Region-wise, the AI in Cancer Diagnostics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the AI in cancer diagnostics market in 2021. The growing cancer prevalence along with the accessibility of the updated healthcare infrastructure propel the growth of the market. However, the increasing government initiatives and the expenditure in the healthcare sector drive the growth of AI in the medical sector. The growing number of patient's diagnostic propels the growth of AI in cancer diagnostics in this region.
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Microsoft Corporation is the forerunner in the AI In Cancer Diagnostics Market. Companies such as Flatiron Health (F. Hoffmann-La Roche Ltd.), Paige AI, Inc., PathAI, Inc. are some of the key innovators in AI In Cancer Diagnostics Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
Recent Strategies Deployed in AI In Cancer Diagnostics Market
Partnership, Collaboration and Agreement:
Nov-2022: Flatiron Health came into partnership with Caris Life Sciences (Caris), the leading molecular science and technology company. Through this partnership, the company aimed at broadening access to precision medicine at the point of care with seamless ordering and receipt of Caris molecular profiling by integrating OncoEMR platform, a leading cloud-based electronic medical record (EMR) tool.
Aug-2022: PathAI came into partnership with Bristol Myers Squibb, an American multinational pharmaceutical company. Through this partnership, the company aimed at developing drugs by expanding the use of artificial intelligence (AI).
Jan-2022: Flatiron Health joined hands with NCCHE, a Japanese cancer center that provides cancer medicine. The collaboration is aimed at expanding the company's international presence.
Nov-2021: Kheiron Medical Technologies teamed up with Stanford University, a private research university. This collaboration aimed at using the expertise of the Stanford Center for Artificial Intelligence in Medicine & Imaging to enhance the use of AI in new areas of Oncology.
Oct-2021: PathAI came into partnership with Roche, a biotechnology company that develops and provides drugs and diagnostics. Through this partnership, the company aimed at developing and providing its AI pathology through Roche's uPath enterprise software.
Jun-2021: Kheiron Medical Technologies entered into a partnership with Atlas Medical, a manufacturer and supplier of quality Diagnostic Reagents and Kits. The partnership is aimed at launching Mia, a solution for breast cancer screening that supports radiologists in detecting cancer more accurately.
May-2021: Paige joined hands with Quest Diagnostics, an American clinical laboratory that provides diagnostic insights. Through this collaboration, the company aimed at delivering faster, more accurate, and more informed clinical insights by creating new software.
Mar-2021: Paige came into partnership with Epredia, a global leader in precision cancer diagnostics. Through this partnership, the company aimed at helping pathologists to unlock insights from each sample and provide results to the patient and clinician more quickly by offering a portfolio of software.
Dec-2020: Tempus joined hands with Bayer, a German multinational pharmaceutical and biotechnology company. The collaboration aimed at providing genomic testing access and tailored treatment approaches for the oncology community.
Product Launch and Product Expansion:
May-2022: Therapixel launched MammoScreen - 2D and 3D, an AI-based software that automatically analyzes mammograms and displays a summary report to radiologists, providing breast cancer detection and using prior exams to refine prediction.
Mar-2022: Paige unveiled Paige Breast Lymph Node, an AI medical device software, designed to increase the accuracy and efficiency in the detection of breast cancer. The launch focused on helping pathologists detecting if breast cancer has metastasized to lymph nodes.
Acquisition, Joint Venture and Merger:
Jul-2021: PathAI completed the acquisition of Poplar, the management service organization for Poplar Healthcare PLLC, an industry-leading independent anatomic pathology laboratory services provider. Through this acquisition, the company would be able to integrate testing services into its existing artificial intelligence-powered pathology platform.
Scope of the Study
Market Segments covered in the Report:
By End-user
- Hospital
- Surgical Centers & Medical Institutes
- Others
By Component
- Software Solutions
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer & Cervical Cancer
- Prostate & Colorectal Cancer
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global AI In Cancer Diagnostics Market, by End-user
- 1.4.2 Global AI In Cancer Diagnostics Market, by Component
- 1.4.3 Global AI In Cancer Diagnostics Market, by Cancer Type
- 1.4.4 Global AI In Cancer Diagnostics Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenarios
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
Chapter 4. Global AI In Cancer Diagnostics Market by End-user
- 4.1 Global Hospital Market by Region
- 4.2 Global Surgical Centers & Medical Institutes Market by Region
- 4.3 Global Others Market by Region
Chapter 5. Global AI In Cancer Diagnostics Market by Component
- 5.1 Global Software Solutions Market by Region
- 5.2 Global Hardware Market by Region
- 5.3 Global Services Market by Region
Chapter 6. Global AI In Cancer Diagnostics Market by Cancer Type
- 6.1 Global Breast Cancer Market by Region
- 6.2 Global Lung Cancer Market by Region
- 6.3 Global Brain Tumor Market by Region
- 6.4 Global Skin Cancer & Cervical Cancer Market by Region
- 6.5 Global Prostate & Colorectal Cancer Market by Region
- 6.6 Global Others Market by Region
Chapter 7. Global AI In Cancer Diagnostics Market by Region
- 7.1 North America AI In Cancer Diagnostics Market
- 7.1.1 North America AI In Cancer Diagnostics Market by End-user
- 7.1.1.1 North America Hospital Market by Country
- 7.1.1.2 North America Surgical Centers & Medical Institutes Market by Country
- 7.1.1.3 North America Others Market by Country
- 7.1.2 North America AI In Cancer Diagnostics Market by Component
- 7.1.2.1 North America Software Solutions Market by Country
- 7.1.2.2 North America Hardware Market by Country
- 7.1.2.3 North America Services Market by Country
- 7.1.3 North America AI In Cancer Diagnostics Market by Cancer Type
- 7.1.3.1 North America Breast Cancer Market by Country
- 7.1.3.2 North America Lung Cancer Market by Country
- 7.1.3.3 North America Brain Tumor Market by Country
- 7.1.3.4 North America Skin Cancer & Cervical Cancer Market by Country
- 7.1.3.5 North America Prostate & Colorectal Cancer Market by Country
- 7.1.3.6 North America Others Market by Country
- 7.1.4 North America AI In Cancer Diagnostics Market by Country
- 7.1.4.1 US AI In Cancer Diagnostics Market
- 7.1.4.1.1 US AI In Cancer Diagnostics Market by End-user
- 7.1.4.1.2 US AI In Cancer Diagnostics Market by Component
- 7.1.4.1.3 US AI In Cancer Diagnostics Market by Cancer Type
- 7.1.4.2 Canada AI In Cancer Diagnostics Market
- 7.1.4.2.1 Canada AI In Cancer Diagnostics Market by End-user
- 7.1.4.2.2 Canada AI In Cancer Diagnostics Market by Component
- 7.1.4.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
- 7.1.4.3 Mexico AI In Cancer Diagnostics Market
- 7.1.4.3.1 Mexico AI In Cancer Diagnostics Market by End-user
- 7.1.4.3.2 Mexico AI In Cancer Diagnostics Market by Component
- 7.1.4.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
- 7.1.4.4 Rest of North America AI In Cancer Diagnostics Market
- 7.1.4.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
- 7.1.4.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
- 7.1.4.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type
- 7.1.4.1 US AI In Cancer Diagnostics Market
- 7.1.1 North America AI In Cancer Diagnostics Market by End-user
- 7.2 Europe AI In Cancer Diagnostics Market
- 7.2.1 Europe AI In Cancer Diagnostics Market by End-user
- 7.2.1.1 Europe Hospital Market by Country
- 7.2.1.2 Europe Surgical Centers & Medical Institutes Market by Country
- 7.2.1.3 Europe Others Market by Country
- 7.2.2 Europe AI In Cancer Diagnostics Market by Component
- 7.2.2.1 Europe Software Solutions Market by Country
- 7.2.2.2 Europe Hardware Market by Country
- 7.2.2.3 Europe Services Market by Country
- 7.2.3 Europe AI In Cancer Diagnostics Market by Cancer Type
- 7.2.3.1 Europe Breast Cancer Market by Country
- 7.2.3.2 Europe Lung Cancer Market by Country
- 7.2.3.3 Europe Brain Tumor Market by Country
- 7.2.3.4 Europe Skin Cancer & Cervical Cancer Market by Country
- 7.2.3.5 Europe Prostate & Colorectal Cancer Market by Country
- 7.2.3.6 Europe Others Market by Country
- 7.2.4 Europe AI In Cancer Diagnostics Market by Country
- 7.2.4.1 Germany AI In Cancer Diagnostics Market
- 7.2.4.1.1 Germany AI In Cancer Diagnostics Market by End-user
- 7.2.4.1.2 Germany AI In Cancer Diagnostics Market by Component
- 7.2.4.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
- 7.2.4.2 UK AI In Cancer Diagnostics Market
- 7.2.4.2.1 UK AI In Cancer Diagnostics Market by End-user
- 7.2.4.2.2 UK AI In Cancer Diagnostics Market by Component
- 7.2.4.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
- 7.2.4.3 France AI In Cancer Diagnostics Market
- 7.2.4.3.1 France AI In Cancer Diagnostics Market by End-user
- 7.2.4.3.2 France AI In Cancer Diagnostics Market by Component
- 7.2.4.3.3 France AI In Cancer Diagnostics Market by Cancer Type
- 7.2.4.4 Russia AI In Cancer Diagnostics Market
- 7.2.4.4.1 Russia AI In Cancer Diagnostics Market by End-user
- 7.2.4.4.2 Russia AI In Cancer Diagnostics Market by Component
- 7.2.4.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
- 7.2.4.5 Spain AI In Cancer Diagnostics Market
- 7.2.4.5.1 Spain AI In Cancer Diagnostics Market by End-user
- 7.2.4.5.2 Spain AI In Cancer Diagnostics Market by Component
- 7.2.4.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
- 7.2.4.6 Italy AI In Cancer Diagnostics Market
- 7.2.4.6.1 Italy AI In Cancer Diagnostics Market by End-user
- 7.2.4.6.2 Italy AI In Cancer Diagnostics Market by Component
- 7.2.4.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
- 7.2.4.7 Rest of Europe AI In Cancer Diagnostics Market
- 7.2.4.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
- 7.2.4.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
- 7.2.4.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
- 7.2.4.1 Germany AI In Cancer Diagnostics Market
- 7.2.1 Europe AI In Cancer Diagnostics Market by End-user
- 7.3 Asia Pacific AI In Cancer Diagnostics Market
- 7.3.1 Asia Pacific AI In Cancer Diagnostics Market by End-user
- 7.3.1.1 Asia Pacific Hospital Market by Country
- 7.3.1.2 Asia Pacific Surgical Centers & Medical Institutes Market by Country
- 7.3.1.3 Asia Pacific Others Market by Country
- 7.3.2 Asia Pacific AI In Cancer Diagnostics Market by Component
- 7.3.2.1 Asia Pacific Software Solutions Market by Country
- 7.3.2.2 Asia Pacific Hardware Market by Country
- 7.3.2.3 Asia Pacific Services Market by Country
- 7.3.3 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
- 7.3.3.1 Asia Pacific Breast Cancer Market by Country
- 7.3.3.2 Asia Pacific Lung Cancer Market by Country
- 7.3.3.3 Asia Pacific Brain Tumor Market by Country
- 7.3.3.4 Asia Pacific Skin Cancer & Cervical Cancer Market by Country
- 7.3.3.5 Asia Pacific Prostate & Colorectal Cancer Market by Country
- 7.3.3.6 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific AI In Cancer Diagnostics Market by Country
- 7.3.4.1 China AI In Cancer Diagnostics Market
- 7.3.4.1.1 China AI In Cancer Diagnostics Market by End-user
- 7.3.4.1.2 China AI In Cancer Diagnostics Market by Component
- 7.3.4.1.3 China AI In Cancer Diagnostics Market by Cancer Type
- 7.3.4.2 Japan AI In Cancer Diagnostics Market
- 7.3.4.2.1 Japan AI In Cancer Diagnostics Market by End-user
- 7.3.4.2.2 Japan AI In Cancer Diagnostics Market by Component
- 7.3.4.2.3 Japan AI In Cancer Diagnostics Market by Cancer Type
- 7.3.4.3 India AI In Cancer Diagnostics Market
- 7.3.4.3.1 India AI In Cancer Diagnostics Market by End-user
- 7.3.4.3.2 India AI In Cancer Diagnostics Market by Component
- 7.3.4.3.3 India AI In Cancer Diagnostics Market by Cancer Type
- 7.3.4.4 South Korea AI In Cancer Diagnostics Market
- 7.3.4.4.1 South Korea AI In Cancer Diagnostics Market by End-user
- 7.3.4.4.2 South Korea AI In Cancer Diagnostics Market by Component
- 7.3.4.4.3 South Korea AI In Cancer Diagnostics Market by Cancer Type
- 7.3.4.5 Singapore AI In Cancer Diagnostics Market
- 7.3.4.5.1 Singapore AI In Cancer Diagnostics Market by End-user
- 7.3.4.5.2 Singapore AI In Cancer Diagnostics Market by Component
- 7.3.4.5.3 Singapore AI In Cancer Diagnostics Market by Cancer Type
- 7.3.4.6 Malaysia AI In Cancer Diagnostics Market
- 7.3.4.6.1 Malaysia AI In Cancer Diagnostics Market by End-user
- 7.3.4.6.2 Malaysia AI In Cancer Diagnostics Market by Component
- 7.3.4.6.3 Malaysia AI In Cancer Diagnostics Market by Cancer Type
- 7.3.4.7 Rest of Asia Pacific AI In Cancer Diagnostics Market
- 7.3.4.7.1 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user
- 7.3.4.7.2 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component
- 7.3.4.7.3 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
- 7.3.4.1 China AI In Cancer Diagnostics Market
- 7.3.1 Asia Pacific AI In Cancer Diagnostics Market by End-user
- 7.4 LAMEA AI In Cancer Diagnostics Market
- 7.4.1 LAMEA AI In Cancer Diagnostics Market by End-user
- 7.4.1.1 LAMEA Hospital Market by Country
- 7.4.1.2 LAMEA Surgical Centers & Medical Institutes Market by Country
- 7.4.1.3 LAMEA Others Market by Country
- 7.4.2 LAMEA AI In Cancer Diagnostics Market by Component
- 7.4.2.1 LAMEA Software Solutions Market by Country
- 7.4.2.2 LAMEA Hardware Market by Country
- 7.4.2.3 LAMEA Services Market by Country
- 7.4.3 LAMEA AI In Cancer Diagnostics Market by Cancer Type
- 7.4.3.1 LAMEA Breast Cancer Market by Country
- 7.4.3.2 LAMEA Lung Cancer Market by Country
- 7.4.3.3 LAMEA Brain Tumor Market by Country
- 7.4.3.4 LAMEA Skin Cancer & Cervical Cancer Market by Country
- 7.4.3.5 LAMEA Prostate & Colorectal Cancer Market by Country
- 7.4.3.6 LAMEA Others Market by Country
- 7.4.4 LAMEA AI In Cancer Diagnostics Market by Country
- 7.4.4.1 Brazil AI In Cancer Diagnostics Market
- 7.4.4.1.1 Brazil AI In Cancer Diagnostics Market by End-user
- 7.4.4.1.2 Brazil AI In Cancer Diagnostics Market by Component
- 7.4.4.1.3 Brazil AI In Cancer Diagnostics Market by Cancer Type
- 7.4.4.2 Argentina AI In Cancer Diagnostics Market
- 7.4.4.2.1 Argentina AI In Cancer Diagnostics Market by End-user
- 7.4.4.2.2 Argentina AI In Cancer Diagnostics Market by Component
- 7.4.4.2.3 Argentina AI In Cancer Diagnostics Market by Cancer Type
- 7.4.4.3 UAE AI In Cancer Diagnostics Market
- 7.4.4.3.1 UAE AI In Cancer Diagnostics Market by End-user
- 7.4.4.3.2 UAE AI In Cancer Diagnostics Market by Component
- 7.4.4.3.3 UAE AI In Cancer Diagnostics Market by Cancer Type
- 7.4.4.4 Saudi Arabia AI In Cancer Diagnostics Market
- 7.4.4.4.1 Saudi Arabia AI In Cancer Diagnostics Market by End-user
- 7.4.4.4.2 Saudi Arabia AI In Cancer Diagnostics Market by Component
- 7.4.4.4.3 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type
- 7.4.4.5 South Africa AI In Cancer Diagnostics Market
- 7.4.4.5.1 South Africa AI In Cancer Diagnostics Market by End-user
- 7.4.4.5.2 South Africa AI In Cancer Diagnostics Market by Component
- 7.4.4.5.3 South Africa AI In Cancer Diagnostics Market by Cancer Type
- 7.4.4.6 Nigeria AI In Cancer Diagnostics Market
- 7.4.4.6.1 Nigeria AI In Cancer Diagnostics Market by End-user
- 7.4.4.6.2 Nigeria AI In Cancer Diagnostics Market by Component
- 7.4.4.6.3 Nigeria AI In Cancer Diagnostics Market by Cancer Type
- 7.4.4.7 Rest of LAMEA AI In Cancer Diagnostics Market
- 7.4.4.7.1 Rest of LAMEA AI In Cancer Diagnostics Market by End-user
- 7.4.4.7.2 Rest of LAMEA AI In Cancer Diagnostics Market by Component
- 7.4.4.7.3 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type
- 7.4.4.1 Brazil AI In Cancer Diagnostics Market
- 7.4.1 LAMEA AI In Cancer Diagnostics Market by End-user
Chapter 8. Company Profiles
- 8.1 Microsoft Corporation
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Partnerships, Collaborations, and Agreements:
- 8.3 Paige AI, Inc.
- 8.3.1 Company Overview
- 8.3.2 Recent strategies and developments:
- 8.3.2.1 Partnerships, Collaborations, and Agreements:
- 8.3.2.2 Product Launches and Product Expansions:
- 8.4 PathAI, Inc.
- 8.4.1 Company Overview
- 8.4.2 Recent strategies and developments:
- 8.4.2.1 Partnerships, Collaborations, and Agreements:
- 8.4.2.2 Acquisition and Mergers:
- 8.5 Therapixel
- 8.5.1 Company Overview
- 8.5.2 Recent strategies and developments:
- 8.5.2.1 Product Launches and Product Expansions:
- 8.6 Tempus, Inc.
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Partnerships, Collaborations, and Agreements:
- 8.7 SkinVision BV
- 8.7.1 Company Overview
- 8.8 Cancer Center Sp. z o.o.
- 8.8.1 Company Overview
- 8.9 Medial EarlySign
- 8.9.1 Company Overview
- 8.10. Kheiron Medical Technologies Limited
- 8.10.1 Company Overview
- 8.10.2 Recent strategies and developments:
- 8.10.2.1 Partnerships, Collaborations, and Agreements:
